SCHEMBL3343784

SCHEMBL3343784

Cc1nc(C(=O)N2CCOC2C(N)=O)c(-c2ccc(F)cc2)s1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 20/20 0.51
HCRTR2 O43614 15/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343687 0.87 HCRTR1 (0.45) HCRTR1HCRTR2
SCHEMBL3343763 0.87 HCRTR1 (0.49) HCRTR1HCRTR2
SCHEMBL3350782 0.86 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL3343787 0.84 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL3348068 0.84 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL3348271 0.83 HCRTR1 (0.40) HCRTR1HCRTR2
SCHEMBL1398904 0.82 HCRTR1 (0.56) HCRTR1HCRTR2
SCHEMBL2056988 0.80 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL1027554 0.79 HCRTR1 (0.55) HCRTR1HCRTR2
SCHEMBL4830480 0.78 HCRTR1 (0.51) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010038200-A1 OXAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-04-08 WO claimed
WO-2010038200-A1 OXAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-04-08 WO disclosed